2.16 USD
↘ 0.43 (16.60%)AT CLOSE (11:59 AM EDT)
TuHURA Biosciences, Inc. Common Stock
HURANASDAQ • USD
2.23
↗ 0.07 (3.24%)
POST MARKET (AS OF 07:53 PM EDT)
Post Market
AS OF 07:53 PM EDT
2.23
↗ 0.07 (3.24%)
Market: CLOSED
TuHURA Biosciences, Inc. Common Stock (HURA) is currently trading at $2.16. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. HURA is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$2.53
High?$2.59
Low?$2.16
Prev. Close?$2.59
Volume?4.5M
Avg. Volume?673.0K
VWAP?$2.33
Rel. Volume?6.70x
Bid / Ask
Bid?$1.90 × 100
Ask?$2.60 × 100
Spread?$0.70
Midpoint?$2.25
Valuation & Ratios
Market Cap?137.6M
Shares Out?63.7M
Float?24.3M
Float %?38.1%
P/E Ratio?N/A
P/B Ratio?5.93
EPS?-$0.49
Dividend?0.01%
Ex-Dividend?N/A
News
Profile
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Employees
22
Market Cap
164.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-18
Address
10500 UNIVERSITY CENTER DR.
TAMPA, FL 33612
Phone: 813-875-6600
TAMPA, FL 33612
Phone: 813-875-6600
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?39
Momentum?50
Short Sent.?35
Piotroski F-Score?0/9Weak
Altman Z-Score?2.11Grey
Confidence?49%Low
Short InterestSqueeze Risk
Short % of Float?31.96%Squeeze Risk
Short Interest?7.8M
Days to Cover?16.6
Free Float24.3M
Avg Daily Volume467.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?1.15Adequate
Quick Ratio?1.15Adequate
Cash Ratio?1.04Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.93FAIR▾
Peers100
S&P31
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.6CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-133.4%WEAK▾
S&P3
ROA?-104.1%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-27385938
Enterprise Value?$131.3M
Fundamentals ratios updated end of day